[ Archive Home ]
Medi-Rad| [ Archive Home ] |
| Medi-Rad |
(Post 1 of 232) 03/15/2000.02:40:00 |
| Author : |
Medi-Rad launches IPO of 32.0 mln new shares at 0.23 sgd each Medi-Rad Associates Ltd said it has launched an IPO of 32.0 mln new shares at 0.23 sgd each. Of the total number of shares, 13.75 mln will be offered to the public and 18.250 mln will be placed with investors, of which 8.0 mln shares are reserved for employees and business associates, it said. The offer price represents a price earnings ratio of 19.70 times based on 1999 results, it added. Medi-Rad is the radiology unit of Parkway Group Heathcare, a subsidiary of Parkway Holdings Ltd. |
| (Post 2 of 232) 03/15/2000.02:50:00 |
| Author : |
Medi-Rad to spend two-third of 16 mln sgd investment in 12 mjths Medi-Rad Associates Ltd, the radiology arm of Parkway Group Healthcare Pte Ltd, said it would spend two-thirds of its 16 mln sgd capital investment in the next 12 months, managing director Robert Kwok said. The company today launched an IPO of 32.0 mln new shares at 0.23 sgd each, which is set to close on March 21. The Development Bank of Singapore is the manager, underwriter and placement agent for the offering. Kwok said the company would expand its MRI Services, network of clinics in Singapore, nuclear medicine services, investment in high-end technology, and investment in multislice CT scanners. He said the company's regional expansion plans will cover Thailand, Malaysia and Indonesia, but added that it currently does not have a fixed time frame for its expansion strategy. "We are currently holding discussions with potentiall working partners in Malaysia and Australia. There is no assurance at this point of time that these discussion will be successful." Commenting on the expansion of its network of clinics, he said two clinics will be set up in the next 12 months in Singapore. "We estimate that the cost of investment in two additional service locations will be approximately 3.5 mln sgd," the company said in the IPO prospectus. He said the investment would be financed from the IPO proceeds and internal cash resources and future working capital. Financial controller Sardool Singh said Medi-Rad expects to raise about 6. 5 mln sgd from the IPO, adding that the rest of its capital investment would be contributed by cash reserves of 6 mln and an operating cashflow of 4 mln. Singh said Medi-Rad booked a turnover of 13.4 mln sgd in 1999, for a pretax profit of 2.2 mln and after tax profit of 1.6 mln. |
| (Post 3 of 232) 11/26/1999.14:53:00 |
| Author : |
Sorry... I am a little too lazy and ignorant of these things to know, but the annual report issued just yesterday will state the revenue and profits of the medi-rad arm right? Does anyone have these info to share? Thanks! |
| (Post 4 of 232) 03/20/2000.14:58:00 |
| Author : |
Medi Rad IPO closes on Tuesday 21 Mar 00. Medi Rad is one of Parkway's subsidiaries. Track record has been volatile. It small float of slightly over 20m shares at low price of 23c, coupled with the recent sterling performances of similar small cap IPOs such as CEI and Khyosha is indicative of what Medi Rad is capable of on its debut. I'd STAG the issue. |
| (Post 5 of 232) 03/21/2000.08:32:00 |
| Author : |
Thoughts on Medi-Rad With only 32 mil shares at an offer price of 23cts, there will not be many shares floating around. This is especially true since Parkway controls the other 67.5% of the equity. This offer will raise $6.6 mil. As this is a capital intensive business, as can be seen from the prospectus which states that 2 additional service facilities will cost the company $3.5 mil, I will not be surprised if it needs to raise more money as it expands overseas. MRI and CTScan equipment do not come cheap. The earnings report has not been very stable in the last few years. The actuals for 1997 showed a turnover of $14 mil and an earnings per share of 1.5cts. In 1998, the turnover was down to $11.5 mil and an EPS of 0.8cts. The forecast for year ending 1999 is for turnover to be $13.3 mil and an EPS of 1.2cts giving a PE ratio of 19.7 on the issued price of 23cts. Nevertheless, this is a relatively safe investment as healthcare is a stable business. One will also assume that the Parkway group will continue to contribute significantly to the revenues as they will still remain the majority shareholder. Certainly a counter that I will revisit once the market hots up again. Its small float is attractive together with its low absolute price and relatively stable income stream. As this is a core business of the Parkway Group, control of this company is likely to always remain within the group. |
| (Post 6 of 232) 03/21/2000.10:02:00 |
| Author : |
Oldman, Correct me if I'm wrong, but Medi-Rad is in the Lab & diagnostics evaluation business. That is an elective medical tool that more and more doctors in private practice are turning towards to aid in health screening. I can appreciate that the high cost of MRI and CT-scan machines raises the barrier to entry for other competitors. Their partnership with Parkway, the biggest hospital player, creates a valuable business link for medical referrals. However, very few insurance policies currently cover this diagnostic practise, neither does the CPF medisheild? How can the average patient afford to pay for their servcies? |
| (Post 7 of 232) 03/21/2000.10:11:00 |
| Author : |
DMG & Partners Medi-Rad Associates Limited, whose initial public offer is scheduled to close today, is an AVOID in the books of DMG. Although the Group has managed to maintain a profitable track record and valuation for the stock is deemed fair, the broking house believes the stock is likely to stage a lackluster debut due mainly to thin market interests. At its offer price of SGD0.23 per share, Medi-Rad is valued at 21.0 times FY00 earnings and 17.8 times FY01 earnings. This compares with the industry’s price earnings ratio of 4.0 to 40.0 times (Note : Medi-Rad is the radiology arm of Parkway Holdings, offering a wide range of comprehensive radiology services). |
| (Post 8 of 232) 03/21/2000.10:48:00 |
| Author : |
Warren, MediRad is the radiology division of the Parkway Group. Parkway Laboratory Services is the lab division that will be floated later. Yes, I am told that lab services are a lot more profitable than the radiology services in Singapore (Interestingly, in the US, radiologist are among the top earners....not here). Maybe that is why Parkway wants to float the Radiology division first. |
| (Post 9 of 232) 03/21/2000.21:40:00 |
| Author : |
Medi-Rad worth a 2nd look... Looks like a stag but I think, they have a good client base With Parkway, SAF and many government and civil service medical organisation as clients, there should be no shortages of business I have the feeling that the recent volatility of their earnings maybe more a results of the financial crisis then anything. So looking at the size of the issue and relative low listing price, it doesn't take a lot of cash for speculator to move it a bit.... |
| (Post 10 of 232) 03/22/2000.07:34:00 |
| Author : |
Medi-Rad IPO retail tranche 27.40 times subscribed Parkway Holdings Ltd said the retail tranche of its unit Medi-Rad Associates Ltd's initial public offering was 27.40 times subscribed at the close of the IPO. Medi-Rad sold 32.0 mln new shares via the IPO, including 13.75 mln shares in the retail tranche, 10.25 mln shares for the placement shares and 8.0 mln shares reserved to employees and business associates, at 0.23 sgd each. The radiology and imaging company is expected to start trading on March 23. |
| (Post 11 of 232) 03/22/2000.16:55:00 |
| Author : |
MEDI-RAD ASSOCIATES LTD (Incorporated in the Republic of Singapore on 30 July 1982) Invitation in respect of 32,000,000 New Shares of $0.05 each comprising :- (1) 13,750,000 Offer Shares at $0.23 for each Offer Share by way of public offer; and (2) 18,250,000 Placement Shares by way of placement, comprising:- (a) 8,000,000 Reserved Shares at $0.23 for each Share reserved for the employees, Directors and business associates of the Group; and (b) 10,250,000 Placement Shares at $0.23 for each Placement Share,payable in full on application The Board of Directors of Medi-Rad Associates Ltd ("Medi-Rad" or the "Company") is pleased to announce that, at the close of the Application List at 12:00 noon on 21 March 2000, there were 16,357 applications for the 13,750,000 Offer Shares available to the public for subscription. In total, these applicants applied for 376,407,000 Offer Shares, with application moneys received amounting to approximately $86.6 million. Based on the 13,750,000 Offer Shares available to the public for subscription, the offer to the public is approximately 27.4 times subscribed. The Shares will commence trading on a "ready" basis on 23 March 2000. There will be NO trading on a "when issued" basis. The return of unsuccessful applications using printed Application Forms by ordinary post at the risk of the unsuccessful applicants, together with the full amount of the application moneys (without interest or any share of revenue or other benefit arising therefrom), will commence today and is expected to be completed by 27 March 2000. For unsuccessful Electronic Applications, it is expected that the full amount of the application moneys (without interest or any share of revenue or other benefit arising therefrom) will be credited to the applicants' accounts with their Participating Banks (as defined in the Prospectus dated 13 March 2000) within three market days after the close of the Application List on 21 March 2000. In respect of partially successful applications, the balance of the application moneys is expected to be refunded (without any interest or any share of revenue or other benefit arising therefrom) to the applicants, by ordinary post at their own risk (in the case of applications made using printed Application Forms) or through the crediting of the relevant amount to the applicants' accounts with their Participating Banks (in the case of Electronic Applications), within 14 days after the close of the Application List on 21 March 2000. The Board of Directors of Medi-Rad is pleased to advise that CPF members may, with effect from 23 March 2000, use their CPF savings (subject to the 50 per cent. sub-limit), to purchase the Company's Shares under and subject to the requirements of the CPF investment Scheme. The Company wishes to thank the public, who have applied for the Offer Shares and the Placement Shares, the relevant authorities and all who have helped in one way or another in the Company's initial public offering, for their support and assistance. Issued by The Development Bank of Singapore Ltd For and on behalf of Medi-Rad Associates Ltd Submitted by Julie Yeo, Vice President on 22/03/2000 to the SES |
| (Post 12 of 232) 03/23/2000.09:32:00 |
| Author : |
auction going on finally ... *hehehe* how high folks!??? |
| (Post 13 of 232) 03/23/2000.09:45:00 |
| Author : |
Hold yor to it if you have....!!! Rad_Makes_Debut_At_S_0.28_Vs_IPO_S_0.23.html A UOB Investment Research report said the company's future earnings growth will be highly boosted by the city-state's aging population. (http://sg.biz.yahoo.com/news/singapore/dowjones/article.html?s=sgfinance/news/000323/singapore/dowjones/Singapore_s_Medi-) I got 4 lots. sold at $0.31. shld have waited..... |
| (Post 14 of 232) 03/23/2000.12:06:00 |
| Author : |
Medi-Rad sharply higher vs IPO price Shares of Parkway Holdings unit Medi-Rad Associates Ltd were sharply higher against its IPO price in late morning trade as the stock is seen as being undervalued against other healthcare companies, dealers said. The gains in Medi-Rad are also boosting the share price of parent Parkway Holdings, they added. "It is a financially sound X-ray company. It has a return on equity of 15. 0 pct and is debt-free," an analyst with a local brokerage said. She said the stock is undervalued compared to other listed healthcare companies. There is no other radiology specialist listed in Singapore and the company can only be compared to the price-earnings ratio of Parkway and Raffles Medical, both of which are trading at above 40 times 1999 PER, she said. Medi-Rad achieved a net profit of 1.603 mln sgd in 1999 against 806,000 in 1998. In 2000, the analyst said she expects Medi-Rad to achieve a net profit of over 2.0 mln sgd. |
| (Post 15 of 232) 03/25/2000.06:47:00 |
| Author : |
PARKWAY HOLDINGS LIMITED Notice Of Changes in Medi-Rad Associates Ltd's Director's Interests - Dr. Ngoi Sing Shang . Name of director: Dr. Ngoi Sing Shang Date of notice to company: 24/03/2000 Date of change of interest: 23/03/2000 Name of registered holder: Dr. Ngoi Sing Shang Circumstance giving rise to the change:Sales in open market at own discretion No. of shares of the change: 20,000 % of issued share capital: 0.0119 Amount of consideration per share excluding brokerage,GST,stamp duties,clearing fee: S$0.335 No. of shares held before change: 100,000 % of issued share capital: 0.0593 No. of shares held after change: 80,000 % of issued share capital: 0.0474 Submitted by June Tay Kwok Fung, Company Secretary on 24/03/2000 to the SES |
| (Post 16 of 232) 03/25/2000.08:52:00 |
| Author : |
Hmmm, what does it say when a director STAGS his own company's shares on IPO? |
| (Post 17 of 232) 03/25/2000.08:53:00 |
| Author : |
By the way, isn't there a 6 month moratorium on this sort of thing? |
| (Post 18 of 232) 03/25/2000.09:09:00 |
| Author : |
Moratoriums are only for the majority shareholders. As this director only owns 0.05% of the company, it does not apply to him. |
| (Post 19 of 232) 03/29/2000.07:26:00 |
| Author : |
MEDI-RAD ASSOCIATES LTD Notice Of Director's Shareholding - Robert Tan Kah Boh . Name of director: Robert Tan Kah Boh Date of notice to company: 28/03/2000 Date of change of interest: 23/03/2000 Name of registered holder: Robert Tan Kah Boh Circumstance giving rise to the change: Others No. of shares of the change: 100,000 % of issued share capital: 0.06 Amount of consideration per share excluding brokerage,GST,stamp duties,clearing fee: 0.23 No. of shares held before change: 0 % of issued share capital: 0 No. of shares held after change: 100,000 % of issued share capital: 0.06 Submitted by June Tay Kwok Fung, Company Secretary on 28/03/2000 to the SES |
| (Post 20 of 232) 03/30/2000.14:03:00 |
| Author : |
Got some during IPO. Feel like selling. Anybody got any advise cause I can see that buying is drying up. |
| (Post 21 of 232) 04/07/2000.07:33:00 |
| Author : |
MEDI-RAD ASSOCIATES LTD Notice Of Changes In Director's / Substantial Shareholder's Interests -Dr. John Hoe . Name of director/substantial shareholder: Dr. John Hoe Wei Ming Date of notice to company: 05/04/2000 Date of change of interest: 05/04/2000 Name of registered holder:Dr. John Hoe Wei Ming Circumstance giving rise to the change:Open market purchase No. of shares of the change: 300,000 % of issued share capital: 0.178 Amount of consideration per share excluding brokerage,GST,stamp duties,clearing fee: S$0.24 No. of shares held before change: 8,400,220 % of issued share capital: 4.982 No. of shares held after change: 8,700,220 % of issued share capital: 5.16 Submitted by June Tay Kwok Fung, Company Secretary on 06/04/2000 to the SES |
| (Post 22 of 232) 02/28/2001.15:54:02 |
| Author : |
MEDI-RAD ASSOCIATES LTD Notice Of Changes In Director's / Substantial Shareholder's Interests - Dr. Robert Kwok . Name of director/substantial shareholder: Dr. Robert Kwok Khoon Date of notice to company: 05/04/2000 Date of change of interest: 05/04/2000 Name of registered holder:Dr. Robert Kwok Khoon Circumstance giving rise to the change:Open market purchase No. of shares of the change: 100,000 % of issued share capital: 0.059 Amount of consideration per share excluding brokerage,GST,stamp duties,clearing fee: S$0.24 No. of shares held before change: 8,400,220 % of issued share capital: 4.98 No. of shares held after change: 8,500,220 % of issued share capital: 5.041 Submitted by June Tay Kwok Fung, Company Secretary on 06/04/2000 to the SES |
| (Post 23 of 232) 05/02/2000.16:06:00 |
| Author : |
[Dow Jones] SINGAPORE STOCK CALL: Fraser-AMMB Research expects 10-15% profit growth for Parkway Laboratory Services in next two years as demand for healthcare services picks up in region. Fraser, which rates stock a buy, has 25x PER for Parkway Labs, which translates into fair value at 55 Singapore cents. [Dow Jones] SINGAPORE: Parkway Holdings likely to list more units in its healthcare services divisions after recent listing of Parkway Labs and Medi-Rad, Business Times quotes Parkway managing director Tony Tan as saying. Such listings will mean more cash for Parkway as it goes about making more regional hospital acquisitions, analysts say. |
| (Post 24 of 232) 05/03/2000.10:23:00 |
| Author : |
Why the large vol of trade for this counter today? Any gossip in the pipeline about this counter? |
| (Post 25 of 232) 05/04/2000.04:11:00 |
| Author : |
MEDI-RAD ASSOCIATES LTD FOR IMMEDIATE RELEASE For enquiries please contact: Dr Kenneth Thean General Manager Medi-Rad Associates Ltd Tel: 8364694 Fax: 8364791 Tan Peck Hwa Director Asia Business Channels Pte Ltd Tel: 832 5185 Fax:542 5672 email:tphcomms@mbox2.singnet.com.sg \bPMedi-Rad boosts its operations with the acquisition of a new high speed helical CT Scanner} SINGAPORE 3 May 2000 Sesdaq listed Medi-Rad Associates Ltd ("Medi-Rad") today announced the acquisition of a new high speed helical multislice Computed Tomography Scanner ("CT"), the Aquillon Multi Helical CT Scanner manufactured by Toshiba Medical Systems Asia Pte Ltd., Japan. This new multislice CT will help Medi-Rad increase its productivity and efficiency as well as offer a wider range of radiology and imaging services to the medical doctors and their patients. The cost of the equipment is $1.8 million. The multislice CT is an improvement in terms of speed over the conventional single-slice CT. With the conventional single-slice CT, one rotation acquires data for just one slice, but with Toshiba's multislice CT, data for four slices are obtained in a single rotation. Other benefits offered by this new equipment include high-speed helical reconstruction which allows 100 images to be reconstructed in only 2 minutes compared to the conventional CT Scan that requires 5 minutes to reconstruct the same number of images. Another benefit offered by this multislice CT lie in its more efficient X-ray utilization, resulting in reduced exposure dose. This new multislice CT also offers an expanded range of applications in routine examinations, cardiac cases, trauma cases, pediatric cases, multiple contrast studies, high-resolution CT (HRCT), CT angiography and many others. In addition the new multislice CT also has a cardiac scoring package for evaluating and quantifying coronary artery calcification. In relation to the purchase of this new multislice CT, Dr Robert Kwok, Managing Director of Medi-Rad has this to say: "During the initial public offering, we committed that we will use the funds to expand and improve the operations of Medi-Rad. This investment in the multislice CT continues the strategy of Medi-Rad Associates Ltd to be one of the leading high technology radiology service provider to Singapore and the region. This acquisition of this multislice scanner will improve the range of services we would be able to offer to patients and the doctors." About Medi-Rad Associates Ltd Medi-Rad Associates Ltd, a subsidiary of Parkway Holdings Ltd, is one of the leading radiology and imaging provider in Singapore. It supports the radiology and imaging requirements of the medical doctors and their patients from both the private and the public sectors. Listed on the Singapore Exchange Dealing and Automated Quotation Systems ("SGX-SESDAQ") on 23 March 2000, the shares of Medi-Rad are traded in the Singapore Exchange. Submitted by June Tay Kwok Fung, Company Secretary on 03/05/2000 to the SES |
| (Post 26 of 232) 05/04/2000.04:14:00 |
| Author : |
MEDI-RAD ASSOCIATES LTD [QUERY FROM SINGAPORE EXCHANGE SECURITIES TRADING LIMITED/ACQUISITION OF EQUIPMENT FOR NEW BRANCHES] Further to the query dated 3 May 2000 from the Singapore Exchange Securities Trading Limited on the sharp increase in the price and the turnover of the Company's shares on the Singapore Exchange Securities Trading Limited today, the Board of Directors of Medi-Rad Associates Ltd ("the Company") wishes to announce that the Board of Directors and substantial shareholders represented on the Board of Directors are not aware of the reason for such sharp increase in the price and turnover. However, the Company hereby announces the acquisition of equipment for new branches as follows :- 1. ACQUISITION OF EQUIPMENT The Board of Directors of the Company is pleased to announce that the Company had purchased a new multislice Computed Tomography Scanner ("CTS") from Toshiba Medical Systems Asia Pte Ltd ("the Vendor"), for the price of S$1.8 million. This will be operated from a new branch of the Company at Mount Elizabeth Medical Centre ("Mount Elizabeth Clinic"). New equipment consisting of a mammography unit, general X-ray unit and 2 ultrasound equipment, costing S$1.1 million ("Equipment A") was also purchased for a new branch of the Company at Gleneagles Hospital ("Gleneagles Clinic") and equipment consisting of a bone densitometer, mammography unit, ultrasound and general X-ray equipment, costing S$0.8 million ("Equipment B") was purchased for another new branch at Paragon ("Paragon Clinic"). The construction costs for Mount Elizabeth Clinic, Gleneagles Clinic and Paragon Clinic is S$0.3million, S$0.4 million and S$0.6 million respectively. 2. FINANCIAL EFFECTS The purchase of the CTS, Equipment A and B will have no material impact on the net tangible assets per share and the earnings per share of the Company for the financial year ending 2000. 3. RATIONALE FOR THE PURCHASE The purchase of the CTS, Equipment A and Equipment B is in line with the Company's strategy of focusing on its business activities with a view to increasing efficiency and productivity. 4. DIRECTORS' AND SUBSTANTIAL SHAREHOLDERS' INTERESTS None of the Directors or substantial shareholders of the Company has any interest, direct or indirect, in the above acquisitions. Submitted by June Tay Kwok Fung, Company Secretary on 03/05/2000 to the SES |
| (Post 27 of 232) 05/06/2000.08:23:00 |
| Author : |
lucky for u Arrow, this counter is trading so high now |
| (Post 28 of 232) 05/08/2000.13:16:00 |
| Author : |
i think we are ready for another re-run |
| (Post 29 of 232) 05/23/2000.16:39:00 |
| Author : |
Hi Mess, Never touch this counter before, make a choice and decide to buy 8 lots @ 0.365. In such weak market, your confident remarks to buy this and PLS helps. Well, thought I have quite a sum of PLS, try this counter lah. so far so good, thanks ;-) regrds |
| (Post 30 of 232) 05/23/2000.16:44:00 |
| Author : |
Web2web, It mezz, not mess or mexx. :) Anyway, this may be the reason for syndicate play pending medi play tonite on DJ, and spill over to SGX tomolo. Cheers! |
| (Post 31 of 232) 05/23/2000.17:45:00 |
| Author : |
hi Mezz.. Thought it not be kind to put ..zzzz... sounds like sleeping but actually awaken. (joke..joke) Thousand apologies, Mezz... Care to put a target to get out... come to think better not, only invites the diehards to short... let them guess, and squeeze them with panic covering... cheers !!! look forward to better showing tomolo lah. regrds |
| (Post 32 of 232) 05/30/2000.16:04:00 |
| Author : |
Parkway Lab is now trading at 0.47. Lets hope that NTUC will be drawn in. This will probably cause the the px to shoot rocket high again and then Medi-Rad can ride on it :-) Vested Interest. |
| (Post 33 of 232) 06/02/2000.11:31:00 |
| Author : |
Hmmm, Medi-rad seems pretty interesting too eh. Anything up? Have a great trading day RaDx |
| (Post 34 of 232) 06/02/2000.14:19:00 |
| Author : |
Anybody got thots on this one?? Volume is creeping up..We're almost 30 calendar days from the last high and prices have corrected 540 degrees from high... 37cts upside?? |
| (Post 35 of 232) 06/02/2000.15:23:00 |
| Author : |
This is one counter that will definitely go up when the situation improves. Bought some lots at .29 and .30. |
| (Post 36 of 232) 06/07/2000.00:00:00 |
| Author : |
Hi, looks like the play has started on this one again. Any comments? RadX |
| (Post 37 of 232) 06/07/2000.14:36:00 |
| Author : |
aiya........... Me so bad luck. In fact wanna buy yesterday but hestitate a bit didnt buy . This morning got a feeling that this time wont be as previous round but itchy hand to buy, so......... Bought $0.54 sold at $0.50.........feel that not seems as previous very strong round....run first. In fact, me this time really buying over boundary....me concentrate more on tech stock but itchy itchy bought this.... Nevermind, still have chance....... |
| (Post 38 of 232) 06/07/2000.14:40:00 |
| Author : |
Prettywoman, Many in SI has learnt many a lesson from the last run-up, and so, are much wiser now.....hope the syndicates get to learn their lesson too....they would if we do not get overcome by greed and boycott them when they ram up the share price.....like for now. |
| (Post 39 of 232) 06/07/2000.16:33:00 |
| Author : |
Pretty Woman, Seems like you have a good judgement.......I have a feeling too this round wont be as previous round. Just look at the price movement, buying force is very week. |
| (Post 40 of 232) 06/07/2000.16:38:00 |
| Author : |
Thankyou moneygame for your praise. This is just my pretty woman intuition. |
| (Post 41 of 232) 06/07/2000.16:46:00 |
| Author : |
Dun know how many ppl will be trapped in this counter again. Hope they will know to escape. |
| (Post 42 of 232) 06/07/2000.22:03:00 |
| Author : |
Anymore upside? |
| (Post 43 of 232) 06/08/2000.16:21:00 |
| Author : |
I guess not...sigh |
| (Post 44 of 232) 06/12/2000.22:41:00 |
| Author : |
What shall I do? Still long @ 0.505 ... still withholding eventhough it broke my support at 0.45 ... help pls ... |
| (Post 45 of 232) 06/12/2000.22:53:00 |
| Author : |
Cut my losses? or Fight to the end? |
| (Post 46 of 232) 06/12/2000.22:54:00 |
| Author : |
No more play in Bio-Tech stocks? Thought I heard something (from a friend) abt govt pumping funds into bio-technology ... care to comment? |
| (Post 47 of 232) 06/13/2000.08:20:00 |
| Author : |
Bio-tech Medi stocks in play this morning. Be on lookout following EDB announcement of growth in this industry. It is exciting with such exponential growth. Watch for Meditec and Zagro as well. |
| (Post 48 of 232) 06/13/2000.23:15:00 |
| Author : |
Finally can breathe once more...*smile*...will there be more action tomorrow? I hear that contra players being forced out today. |
| (Post 49 of 232) 06/14/2000.16:08:00 |
| Author : |
i love my medi-rad...have been dating her & miss medtecs lately...;O) R: 0.49/0.52/0.545 S: 0.45/0.41 vested interests in both. |
| (Post 50 of 232) 06/14/2000.16:32:00 |
| Author : |
Zero-one, Medi-Rad.....a 'her'? .... no wonder she's unavailable to me! .... been queuing to get her the whole of yesterday and this morning ..... decided to join in coz i noticed the support some powerful hands are giving her..... but they just refuse to let me have her *sigh* |
|
Copyright © 2005 ShareInvestor Pte Ltd. All Rights Reserved. Please read our General Disclaimer & Warning carefully. Use of this Website constitutes acceptance of the Terms of Website Use. For Members, please read our Membership Terms and Conditions carefully. |
Design by InfiniteSparks
|